The U.S. Supreme Court Weighs Mifepristone for Abortion Care
An upcoming Supreme Court ruling could put a stop to telehealth abortion services nationally, and limit access to mifepristone, one of two drugs commonly used in abortion care.
University of California San Francisco
Give to UCSF
Can a New Drug Candidate Cure Pancreatic Cancer?
A new drug candidate permanently modifies a wily cancer-causing mutation, paving the way for making pancreatic cancer treatable, or perhaps even curable.
Better Way to Deliver Fetal Therapy for Serious Genetic Disorders
Delivering medicine through amniotic fluid is as effective as delivering it to the fetal brain via cerebrospinal fluid to treat serious disordrs such as Angelman syndrome.
How AI Can Help Spot Early Risk Factors for Alzheimer’s Disease
UCSF scientists found a way to predict Alzheimer’s disease up to seven years before symptoms appear by analyzing patient records with machine learning. Conditions that most influenced prediction of Alzheimer’s were high cholesterol and, for women, osteoporosis.
Bowes Biomedical Investigator Takes Aim at Cracking Cellular Communication Code
Biophysicist Aashish Manglik, MD, PhD, is the newly awarded 2024 Bowes Biomedical Investigator. With the award, he hopes to further the intersection of his GPCR research and neuropsychiatric diseases.
Genetic Discovery Reveals Who Can Benefit from Preterm Birth Therapy
In a first, scientists at UCSF and Stanford identified genetic variants that predict whether a patient is likely to respond to treatment for preterm birth. Screening for mutations could allow doctors to target medications to those most likely to benefit. No medication is currently available in the U.S. to treat preterm birth.
Could Two Drugs Be Better Than One for Treating Prostate Cancer?
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.
Survey Shows Physicians Don’t Understand FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
Corporate Strategy, National Tragedy
UCSF’s industry archives expose the marketing tactics that fueled the opioid epidemic.
Why You Might Not Find Your Favorite Cold Meds at the Pharmacy
The FDA's recent ruling of phenylephrine as ineffective has led major pharmacies and retailers to pull common cold medicines from their shelves.
Over 30 UCSF Scientists Honored for Highest Impact in Their Fields
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.
Do Combination Therapies Hold Hope for Prostate Cancer Patients?
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.